Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
| Conditions: | Malignant Mesothelioma |
| Start Date: | August 1, 1996 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00003263 |
| Study Type: | Interventional |
| Intervention: | Biological: recombinant interferon alfa|Drug: cisplatin|Procedure: surgical procedure|Radiation: radiation therapy |
| Study Design: | Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Fox Chase Cancer Center|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 25 |
| Funded By: | Other|NIH |
| First Received: | November 1, 1999 |
| End Date: | November 1, 2000 |
| Last Updated: | February 11, 2010 |
| Last Verified: | February 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
